Laurion Capital Management LP Q2 2022 Filing
Filed August 15, 2022
Portfolio Value
$6.5B
Holdings
357
Report Date
Q2 2022
Filing Type
13F-HR
All Holdings (357 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | TMOTHERMO FISHER SCIENTIFIC INC | 11,967 | $6.5B | 100.42% | Put |
| 102 | TORCEURADICET BIO INC | 441,518 | $6.4B | 99.55% | |
| 103 | —PROMETHEUS BIOSCIENCES INC | 228,167 | $6.4B | 99.49% | |
| 104 | ALKALASKA AIR GROUP INC | 160,744 | $6.4B | 99.43% | Put |
| 105 | PFEPFIZER INC | 119,557 | $6.3B | 96.81% | Put |
| 106 | AMTAMERICAN TOWER CORP NEW | 23,939 | $6.1B | 94.50% | |
| 107 | CRWDCROWDSTRIKE HLDGS INC | 35,100 | $5.9B | 91.37% | Put |
| 108 | CSXCSX CORP | 203,200 | $5.9B | 91.20% | Call |
| 109 | ABOSACUMEN PHARMACEUTICALS INC | 1,206,548 | $5.7B | 87.59% | |
| 110 | ELANELANCO ANIMAL HEALTH INC | 287,500 | $5.6B | 87.17% | Put |
| 111 | XLFISELECT SECTOR SPDR TR | 75,000 | $5.4B | 83.62% | |
| 112 | ANABANAPTYSBIO INC | 263,208 | $5.3B | 82.52% | |
| 113 | TCRTALAUNOS THERAPEUTICS INC | 4,289,193 | $5.3B | 82.15% | |
| 114 | BMEABIOMEA FUSION INC | 420,149 | $5.0B | 77.73% | |
| 115 | WYNNWYNN RESORTS LTD | 87,025 | $5.0B | 76.57% | Put |
| 116 | NXPINXP SEMICONDUCTORS N V | 32,526 | $4.8B | 74.37% | |
| 117 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 358,380 | $4.7B | 72.79% | |
| 118 | CBAYUSDCYMABAY THERAPEUTICS INC | 1,575,269 | $4.6B | 71.77% | |
| 119 | KALVKALVISTA PHARMACEUTICALS INC | 470,000 | $4.6B | 71.43% | |
| 120 | AHCOADAPTHEALTH CORP | 241,497 | $4.4B | 67.29% | |
| 121 | VORVOR BIOPHARMA INC | 857,308 | $4.3B | 65.81% | |
| 122 | —ICOSAVAX INC | 742,354 | $4.3B | 65.70% | |
| 123 | —EPIZYME INC | 2,885,100 | $4.2B | 65.50% | |
| 124 | GOOGALPHABET INC | 1,894 | $4.1B | 63.99% | |
| 125 | DOWDOW INC | 76,896 | $4.0B | 61.30% | |
| 126 | LULULULULEMON ATHLETICA INC | 14,467 | $3.9B | 60.91% | |
| 127 | MBVIM3 BRIGADE ACQUISITION II CO | 400,000 | $3.9B | 60.54% | |
| 128 | ALDXALDEYRA THERAPEUTICS INC | 971,781 | $3.9B | 59.88% | |
| 129 | LCTXLINEAGE CELL THERAPEUTICS IN | 2,422,367 | $3.8B | 59.11% | |
| 130 | VKTXVIKING THERAPEUTICS INC | 1,323,809 | $3.8B | 59.09% | |
| 131 | PLRXPLIANT THERAPEUTICS INC | 470,601 | $3.8B | 58.23% | |
| 132 | ENQENTEGRIS INC | 35,142 | $3.2B | 49.99% | |
| 133 | GHRSGH RESEARCH PLC | 314,930 | $3.1B | 48.54% | |
| 134 | URGNUROGEN PHARMA LTD | 380,600 | $3.1B | 48.14% | |
| 135 | SRRKSCHOLAR ROCK HLDG CORP | 562,182 | $3.1B | 47.66% | |
| 136 | RLYBRALLYBIO CORP | 402,000 | $3.0B | 46.87% | |
| 137 | ARWRARROWHEAD PHARMACEUTICALS IN | 85,128 | $3.0B | 46.29% | |
| 138 | WVEWAVE LIFE SCIENCES LTD | 871,500 | $2.8B | 43.74% | |
| 139 | METAMETA PLATFORMS INC | 17,316 | $2.8B | 43.12% | |
| 140 | TWO 6.25 01/15/26TWO HARBORS INVENTMENT CORPO | 3,000,000 | $2.8B | 42.47% | |
| 141 | RYIVIRACTA THERAPEUTICS INC | 698,000 | $2.7B | 41.82% | |
| 142 | ZVRAKEMPHARM INC | 582,261 | $2.6B | 40.11% | |
| 143 | YUMCYUM CHINA HLDGS INC | 53,382 | $2.6B | 39.99% | |
| 144 | VMWEURVMWARE INC | 21,587 | $2.5B | 37.99% | |
| 145 | PANWPALO ALTO NETWORKS INC | 4,967 | $2.5B | 37.90% | |
| 146 | TCDA 3.5 05/15/27TRICIDA INC | 4,500,000 | $2.4B | 37.53% | |
| 147 | ATOSEURATOSSA THERAPEUTICS INC | 2,225,800 | $2.4B | 37.47% | |
| 148 | —IKENA ONCOLOGY INC | 529,000 | $2.3B | 36.19% | |
| 149 | CTMXCYTOMX THERAPEUTICS INC | 1,270,900 | $2.3B | 35.92% | |
| 150 | METMETLIFE INC | 36,842 | $2.3B | 35.72% | |
| 151 | HTAEURHEALTHCARE TR AMER INC | 84,459 | $2.3B | 35.48% | |
| 152 | AMGNAMGEN INC | 9,221 | $2.2B | 34.64% | |
| 153 | HOWLWEREWOLF THERAPEUTICS INC | 535,160 | $2.2B | 33.81% | |
| 154 | IHSIHS HOLDING LIMITED | 208,247 | $2.2B | 33.58% | |
| 155 | —AKOUOS INC | 456,000 | $2.1B | 33.04% | |
| 156 | STTKSHATTUCK LABS INC | 506,000 | $2.1B | 31.72% | |
| 157 | CMPSCOMPASS PATHWAYS PLC | 189,407 | $2.0B | 31.65% | |
| 158 | OLMAOLEMA PHARMACEUTICALS INC | 495,300 | $2.0B | 31.14% | |
| 159 | THCTENET HEALTHCARE CORP | 37,428 | $2.0B | 30.38% | |
| 160 | OVVOVINTIV INC | 40,037 | $1.8B | 27.32% | |
| 161 | —RAIN THERAPEUTICS INC | 313,200 | $1.7B | 26.89% | |
| 162 | COHRII-VI INC | 34,126 | $1.7B | 26.86% | |
| 163 | BKNGBOOKING HOLDINGS INC | 980 | $1.7B | 26.49% | Put |
| 164 | FDMT4D MOLECULAR THERAPEUTICS IN | 245,123 | $1.7B | 26.43% | |
| 165 | HOMBHOME BANCSHARES INC | 80,302 | $1.7B | 25.76% | |
| 166 | BRK/BBERKSHIRE HATHAWAY INC DEL | 6,061 | $1.7B | 25.56% | |
| 167 | TSHATAYSHA GENE THERAPIES INC | 442,600 | $1.6B | 25.42% | |
| 168 | —OMEGA THERAPEUTICS INC | 432,700 | $1.6B | 25.39% | |
| 169 | CRDFCARDIFF ONCOLOGY INC | 722,100 | $1.6B | 24.54% | |
| 170 | GRPHGRAPHITE BIO INC | 573,600 | $1.6B | 24.36% | |
| 171 | TRDAENTRADA THERAPEUTICS INC | 129,066 | $1.6B | 24.28% | |
| 172 | MEIPUSDMEI PHARMA INC | 2,576,900 | $1.6B | 24.08% | |
| 173 | AZOAUTOZONE INC | 700 | $1.5B | 23.23% | Call |
| 174 | TVTX 2.25 03/01/29TRAVERE THERAPEUTICS INC | 1,500,000 | $1.5B | 23.17% | |
| 175 | —ION ACQUISITION CORP 3 LTD | 150,000 | $1.5B | 22.60% | |
| 176 | USBUS BANCORP DEL | 30,973 | $1.4B | 22.01% | |
| 177 | HNMORMAT TECHNOLOGIES INC | 18,000 | $1.4B | 21.78% | |
| 178 | PSTXUSDPOSEIDA THERAPEUTICS INC | 545,700 | $1.4B | 21.75% | |
| 179 | —APPLIED MOLECULAR TRANS INC | 481,600 | $1.4B | 21.64% | |
| 180 | —SQZ BIOTECHNOLOGIES CO | 431,400 | $1.4B | 21.19% | |
| 181 | PCGPG&E CORP | 136,617 | $1.4B | 21.05% | |
| 182 | —TALARIS THERAPEUTICS INC | 298,422 | $1.3B | 20.79% | |
| 183 | INZYINOZYME PHARMA INC | 271,800 | $1.3B | 20.02% | |
| 184 | DOYUDOUYU INTL HLDGS LTD | 1,021,467 | $1.2B | 18.93% | |
| 185 | BJBJS WHSL CLUB HLDGS INC | 19,458 | $1.2B | 18.73% | |
| 186 | PRAXPRAXIS PRECISION MEDICINES I | 486,669 | $1.2B | 18.41% | |
| 187 | —9 METERS BIOPHARMA INC | 4,553,084 | $1.2B | 18.33% | |
| 188 | —IMPEL PHARMACEUTICALS INC | 124,800 | $1.2B | 17.96% | |
| 189 | EXECHESAPEAKE ENERGY CORP | 14,342 | $1.2B | 17.96% | |
| 190 | LRNSTRIDE INC | 26,867 | $1.1B | 16.93% | |
| 191 | PFGCPERFORMANCE FOOD GROUP CO | 23,810 | $1.1B | 16.91% | |
| 192 | SURFUSDSURFACE ONCOLOGY INC | 665,400 | $1.1B | 16.85% | |
| 193 | CUCAAVIS BUDGET GROUP | 7,409 | $1.1B | 16.83% | |
| 194 | BILIBILIBILI INC | 42,211 | $1.1B | 16.70% | |
| 195 | CYTCYTEIR THERAPEUTICS INC | 359,500 | $1.1B | 16.60% | |
| 196 | XLESELECT SECTOR SPDR TR | 14,900 | $1.1B | 16.45% | |
| 197 | TTEKTETRA TECH INC NEW | 7,426 | $1.0B | 15.66% | |
| 198 | —THESEUS PHARMACEUTICALS INC | 179,619 | $994.0M | 15.35% | |
| 199 | K6BKBR INC | 19,722 | $954.0M | 14.73% | |
| 200 | HCAHCA HEALTHCARE INC | 5,609 | $943.0M | 14.56% |